Macmiror Complex (Nystatin, Nifuratel)

Nystatin binds to ergosterol in fungal cell membranes, forming pores that cause cell leakage and death. Nifuratel interferes with microbial nucleic acid synthesis and metabolic pathways, providing antibacterial and antiprotozoal activity that complements the antifungal effect.

The dosage regimen for Macmiror Complex is determined by the prescribing healthcare professional based on the specific infection, severity and patient characteristics. Patients should follow the prescriber’s instructions exactly.

Safety data for Macmiror Complex in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To request Macmiror Complex, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Macmiror Complex combines an antifungal (nystatin) with an antimicrobial (nifuratel), offering broader coverage than single‑agent products that target only fungi or bacteria. This dual mechanism can be advantageous when mixed infections are suspected, but choice of therapy should be guided by clinical assessment and microbiological testing.

Store Macmiror Complex at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and ensure the container is tightly closed when not in use.

Macmiror Complex is intended for vaginal administration. The prescribed dosage form is inserted into the vagina according to the prescriber’s directions, typically using an applicator or vaginal tablet, and the treatment course is completed as instructed.

Serious risks include allergic reactions such as facial swelling, severe vaginal ulceration, and rare systemic hypersensitivity that may present with fever or rash. Patients should seek immediate medical attention if any of these symptoms occur.

Macmiror Complex should be avoided by individuals with known hypersensitivity to nystatin, nifuratel or any excipients in the formulation. It is also contraindicated in patients for whom a vaginal anti‑infective is medically inappropriate, as determined by a healthcare professional.